Physician

Ronald L George

According to 2025 Medicare claims, Ronald George (NPI: 1265657894) practices rheumatology in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is WILMINGTON HEALTH PLLC (NPI: 1881632339; TIN: 561980160) and primary practice location at 28401-7684. George is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

George's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 766 traditional Medicare patients, billed 190,738 HCPCS/CPT codes, and received $1,769,269 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,044 prescription claims across 943 beneficiaries totaling $10,044,045 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2022 DME data shows 12 claims. Open Payments data shows 214 records totaling $57,415. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $972,731 to $10,044,045. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,689 and ending at $4,883.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,037	100,748	$1,991,491
2016	1,178	167,427	$2,838,502
2017	1,108	256,044	$3,342,260
2018	1,004	234,176	$2,898,850
2019	1,074	252,690	$2,895,913
2020	963	248,161	$2,659,591
2021	961	249,044	$3,116,780
2022	1,004	269,168	$3,391,324
2023	960	339,636	$3,203,689
2024	766	190,738	$1,769,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	615	3,792	$972,731
2016	757	4,792	$2,423,449
2017	767	4,383	$2,738,890
2018	726	3,962	$3,848,245
2019	862	4,677	$4,111,446
2020	913	5,595	$4,762,194
2021	998	6,584	$6,865,730
2022	950	6,948	$8,080,060
2023	922	6,797	$9,109,259
2024	943	7,044	$10,044,045

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	56	$2,000
2019	N/R	57	$2,052
2020	N/R	69	$2,077
2021	N/R	11	$152
2022	N/R	12	$173
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	529	944	$87
80053	Blood test, comprehensive group of blood chemicals	462	724	$10
36415	Insertion of needle into vein for collection of blood sample	504	865	$9
86140	Measurement c-reactive protein for detection of infection or inflammation	442	710	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	451	742	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	257	7,252	$1,835,685
Skyrizi Pen	Risankizumab-Rzaa	62	4,312	$1,275,738
Enbrel Sureclick	Etanercept	155	4,340	$1,148,124
Cosentyx Sensoready (2 Pens)	Secukinumab	123	3,500	$994,455
Rinvoq	Upadacitinib	107	3,570	$770,885

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	175	$3,404	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	39	$54,011	SUN PHARMACEUTICAL INDUSTRIES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ronald L. George?

Tedicare shows public-source Medicare data for Ronald L. George (NPI 1265657894), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ronald L. George have ACO affiliation data?

Ronald L. George is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ronald L. George?

Ronald L. George is linked to WILMINGTON HEALTH PLLC (billing NPI 1881632339) in the available physician profile data.

Does Ronald L. George have Open Payments data?

Ronald L. George has 214 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.